Investigating the role of isolevuglandins in high blood pressure and lupus

A Role of Isolevuglandins in Essential Hypertension and Systemic Lupus Erythematosus

NIH-funded research Veterans Health Administration · NIH-10948077

This study is looking at how certain molecules from fat breakdown might play a role in high blood pressure and lupus, and it's testing ways to block these molecules to help improve health for people with these conditions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionVeterans Health Administration NIH-funded
Lab location1 site (Nashville, United States)
Project IDNIH-10948077 on NIH RePORTER

What this research studies

This research focuses on understanding how isolevuglandins, which are products of fatty acid oxidation, contribute to essential hypertension and systemic lupus erythematosus (SLE). The study examines how these molecules interact with proteins and activate immune cells, leading to hypertension and autoimmune responses. By using mouse models, the research aims to identify the mechanisms behind these conditions and explore potential treatments, such as isoLG scavengers, that could mitigate their effects.

Who could benefit from this research

Good fit: Ideal candidates for this research include veterans suffering from essential hypertension or systemic lupus erythematosus.

Not a fit: Patients without hypertension or autoimmune conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that specifically target the underlying mechanisms of hypertension and lupus, improving patient outcomes.

How similar studies have performed: Previous studies have shown promising results in understanding the role of isolevuglandins in autoimmune diseases, suggesting that this approach may lead to significant advancements.

Where this research is happening

Nashville, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.